| Case Number | 12013 |
| Request Date | 17/07/2026 |
| Completion Date | 24/08/2026 |
Details of the Request
I am writing to submit a new FOI request about dermatology services at your NHS organisation.
1. In the last 6 months (November 2025 to April 2026), how many adult patients were treated by the dermatology department, excluding patients referred for cancer / suspected cancer?
2. Do you run a specific clinic for patients with atopic dermatitis?
3. In the last 6 months (November 2025 to April 2026), how many adult patients with atopic dermatitis were treated by the dermatology department?
4. In the last 6 months (November 2025 to April 2026), how many adult patients with atopic dermatitis were treated with the following products:
- Immunosuppressants (Azathioprine, Ciclosporin, Methotrexate, Mycophenolate mofetil, Pimecrolimus, or Tacrolimus)
- Abrocitinib
- Baricitinib
- Dupilumab
- Lebrikizumab
- Tralokinumab
- Upadacitinib
- Nemolizumab
- Delgocitinib
5. In the last 6 months (November 2025 to April 2026), how many adult patients with atopic dermatitis were started on the following products:
- Immunosuppressants (Azathioprine, Ciclosporin, Methotrexate, Mycophenolate mofetil, Pimecrolimus, or Tacrolimus)
- Abrocitinib
- Baricitinib
- Dupilumab
- Lebrikizumab
- Tralokinumab
- Upadacitinib
- Nemolizumab
- Delgocitinib
Details of the Response
1. In the last 6 months (November 2025 to April 2026), how many adult patients were treated by the dermatology department, excluding patients referred for cancer / suspected cancer?
119
2. Do you run a specific clinic for patients with atopic dermatitis?
No
3. In the last 6 months (November 2025 to April 2026), how many adult patients with atopic dermatitis were treated by the dermatology department?
5
4. In the last 6 months (November 2025 to April 2026), how many adult patients with atopic dermatitis were treated with the following products:
- Immunosuppressants (Azathioprine, Ciclosporin, Methotrexate, Mycophenolate mofetil, Pimecrolimus, or Tacrolimus) = 0
- Abrocitinib = 0
- Baricitinib = 0
- Dupilumab = <5
- Lebrikizumab = <5
- Tralokinumab = 0
- Upadacitinib = 0
- Nemolizumab = 0
- Delgocitinib = 0
5. In the last 6 months (November 2025 to April 2026), how many adult patients with atopic dermatitis were started on the following products:
- Immunosuppressants (Azathioprine, Ciclosporin, Methotrexate, Mycophenolate mofetil, Pimecrolimus, or Tacrolimus)
- Abrocitinib = 0
- Baricitinib = 0
- Dupilumab = <5
- Lebrikizumab = <5
- Tralokinumab = 0
- Upadacitinib = 0
- Nemolizumab = 0
- Delgocitinib = 0



